Literature DB >> 16432023

Analysis of protein-protein interactions in the feline calicivirus replication complex.

William J Kaiser1, Yasmin Chaudhry, Stanislav V Sosnovtsev, Ian G Goodfellow.   

Abstract

Caliciviruses are a major cause of gastroenteritis in humans and cause a wide variety of other diseases in animals. Here, the characterization of protein-protein interactions between the individual proteins of Feline calicivirus (FCV), a model system for other members of the family Caliciviridae, is reported. Using the yeast two-hybrid system combined with a number of other approaches, it is demonstrated that the p32 protein (the picornavirus 2B analogue) of FCV interacts with p39 (2C), p30 (3A) and p76 (3CD). The FCV protease/RNA polymerase (ProPol) p76 was found to form homo-oligomers, as well as to interact with VPg and ORF2, the region encoding the major capsid protein VP1. A weak interaction was also observed between p76 and the minor capsid protein encoded by ORF3 (VP2). ORF2 protein was found to interact with VPg, p76 and VP2. The potential roles of the interactions in calicivirus replication are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432023     DOI: 10.1099/vir.0.81456-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases.

Authors:  Rowena A Bull; Jennifer Hyde; Jason M Mackenzie; Grant S Hansman; Tomoichiro Oka; Naokazu Takeda; Peter A White
Journal:  Virus Genes       Date:  2010-10-20       Impact factor: 2.332

Review 2.  Structure-function relationships among RNA-dependent RNA polymerases.

Authors:  Kenneth K S Ng; Jamie J Arnold; Craig E Cameron
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

3.  Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells.

Authors:  Stanislav V Sosnovtsev; Gaël Belliot; Kyeong-Ok Chang; Victor G Prikhodko; Larissa B Thackray; Christiane E Wobus; Stephanie M Karst; Herbert W Virgin; Kim Y Green
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 4.  The genome-linked protein VPg of vertebrate viruses - a multifaceted protein.

Authors:  Ian Goodfellow
Journal:  Curr Opin Virol       Date:  2011-10-07       Impact factor: 7.090

5.  Major Capsid Protein Synthesis from the Genomic RNA of Feline Calicivirus.

Authors:  Christian Urban; Christine Luttermann
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

6.  Norovirus RNA synthesis is modulated by an interaction between the viral RNA-dependent RNA polymerase and the major capsid protein, VP1.

Authors:  Chennareddy V Subba-Reddy; Muhammad Amir Yunus; Ian G Goodfellow; C Cheng Kao
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

7.  VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay.

Authors:  Chennareddy V Subba-Reddy; Ian Goodfellow; C Cheng Kao
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

8.  Genetic characterization of feline calicivirus strains associated with varying disease manifestations during an outbreak season in Missouri (1995-1996).

Authors:  Victor G Prikhodko; Carlos Sandoval-Jaime; Eugenio J Abente; Karin Bok; Gabriel I Parra; Igor B Rogozin; Eileen N Ostlund; Kim Y Green; Stanislav V Sosnovtsev
Journal:  Virus Genes       Date:  2013-11-12       Impact factor: 2.332

9.  High-resolution functional profiling of the norovirus genome.

Authors:  Lucy Thorne; Dalan Bailey; Ian Goodfellow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic reticulum to initiate replication complex formation.

Authors:  Dalan Bailey; William J Kaiser; Mike Hollinshead; Katy Moffat; Yasmin Chaudhry; Thomas Wileman; Stanislav V Sosnovtsev; Ian G Goodfellow
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.